25-hydroxyvitamin D is a predictor of COVID-19 severity of hospitalized patients

被引:12
|
作者
Nguyen, Nguyen N. [1 ]
Raju, Muppala N. P. [1 ]
da Graca, Briget [2 ]
Wang, Dapeng [1 ]
Mohamed, Nada A. [1 ]
Mutnal, Manohar B. [1 ]
Rao, Arundhati [1 ]
Bennett, Monica [2 ]
Gokingco, Matthew [1 ]
Huy Pham [1 ]
Mohammad, Amin A. [1 ]
机构
[1] Baylor Scott & White Cent Texas, Dept Pathol, Temple, TX 76508 USA
[2] Baylor Scott & White Res Inst, Dallas, TX USA
来源
PLOS ONE | 2022年 / 17卷 / 05期
关键词
VITAMIN-D; HEALTH;
D O I
10.1371/journal.pone.0268038
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objectives Studies investigating the association between vitamin D and severity of COVID-19 have mixed results perhaps due to immunoassay assessment of total 25-hydroxyvitamin D (tD) (the sum of 25-hydroxyvitamin-D2 [25-OH-D2] and 25-hydroxyvitamin-D3 [25-OH-D3]). Liquid chromatography tandem mass spectrometry (LC-MS/MS) has high analytical specificity and sensitivity for 25-OH-D2 and 25-OH-D3, and thus enables a more accurate assessment of impact on COVID-19 outcomes. Methods We established reference intervals for 25-OH-D3 and tD using LC-MS/MS. 25-OH-D2, 25-OH-D3 and tD were quantitated for 88 COVID-19 positive and 122 COVID-19 negative specimens. Chi-square or Fisher's exact tests were used to test associations in binary variables. T-Tests or Wilcoxon rank sum tests were used for continuous variables. Cox proportional hazards were used to test associations between 25-OH-D3 or tD levels and length of stay (LOS). For mortality and ventilation, logistic regression models were used. Results COVID-19 patients with deficient (<20 ng/mL) levels of 25-OH-D3 had significantly longer LOS by 15.3 days. COVID-19 P patients with deficient (<20 ng/mL) and insufficient (<30 ng/mL) of tD had significantly longer LOS by 12.1 and 8.2 days, respectively. Patients with insufficient levels of tD had significantly longer LOS by 13.7 days. COVID-19 patients with deficient serum 25-OH-D3 levels had significantly increased risk-adjusted odds of in-hospital mortality (OR [95% CI]: 5.29 [1.53-18.24]); those with insufficient 25-OH-D3 had significantly increased risk for requiring ventilation during hospitalization was found at LCMS insufficient cutoff (OR [95% CI]: 2.75 [1.10-6.90]). Conclusions There is an inverse relationship of 25-hydroxyvitamin D levels and hospital LOS for COVID-19 patients. Vitamin D status is a predictor for severity of outcomes. LCMS results are useful for assessing the odds of mortality and the need for ventilation during hospitalization.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Grip strength as a predictor of disease severity in hospitalized COVID-19 patients
    Kara, Ozgur
    Kara, Murat
    Akin, Mustafa Emre
    Ozcakar, Levent
    HEART & LUNG, 2021, 50 (06): : 743 - 747
  • [22] Rising trend in circulating 25-hydroxyvitamin D during the COVID-19 pandemic in Ireland
    Kilbane, M. T.
    Mc Kenna, M. J.
    Twomey, P. J.
    Crowley, R. K.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2022, 191 (SUPPL 4) : 125 - 125
  • [23] Correlation between 25-hydroxyvitamin D/D3 Deficiency and COVID-19 Disease Severity in Adults from Northern Colorado
    Baxter, Bridget A.
    Ryan, Michaela G.
    LaVergne, Stephanie M.
    Stromberg, Sophia
    Berry, Kailey
    Tipton, Madison
    Natter, Nicole
    Nudell, Nikiah
    McFann, Kim
    Dunn, Julie
    Webb, Tracy L.
    Armstrong, Michael
    Reisdorph, Nichole
    Ryan, Elizabeth P.
    NUTRIENTS, 2022, 14 (24)
  • [24] Hypomagnesemia and 25-hydroxyvitamin D deficiency in patients with long COVID
    Guerrero-Romero, Fernando
    Gamboa-Gomez, Claudia I.
    Rodriguez-Moran, Martha
    Orrante, Maya
    Rosales-Galindo, Estefany
    Cisneros-Ramirez, Itzel
    Arce-Quinones, Mariana
    Orona-Diaz, Karen
    Simental-Mendia, Luis E.
    Martinez-Aguilar, Gerardo
    MAGNESIUM RESEARCH, 2023, 36 (03) : 30 - 36
  • [25] Serum 25-hydroxyvitamin D predicts severity and prognosis in stroke patients
    Daubail, B.
    Jacquin, A.
    Guilland, J. -C.
    Hervieu, M.
    Osseby, G. -V.
    Rouaud, O.
    Giroud, M.
    Bejot, Y.
    EUROPEAN JOURNAL OF NEUROLOGY, 2013, 20 (01) : 57 - 61
  • [26] Comment on "Grip strength as a predictor of disease severity in hospitalized COVID-19 patients"
    Sajid, Samar
    HEART & LUNG, 2023, 57 : 296 - 296
  • [27] 25-Hydroxyvitamin D and Severity of Parkinson's Disease
    Chitsaz, Ahmad
    Maracy, Mohammad
    Basiri, Keivan
    Boroujeni, Maryam Izadi
    Tanhaei, Amir Pouya
    Rahimi, Marzieh
    Meamar, Rokhsareh
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2013, 2013
  • [28] Serum 25-hydroxyvitamin D levels and psychological distress symptoms in patients with affective disorders during the COVID-19 pandemic
    Di Nicola, Marco
    Dattoli, Luigi
    Moccia, Lorenzo
    Pepe, Maria
    Janiri, Delfina
    Fiorillo, Andrea
    Janiri, Luigi
    Sani, Gabriele
    PSYCHONEUROENDOCRINOLOGY, 2020, 122
  • [29] 25-Hydroxyvitamin D level is associated with mortality in patients with critical COVID-19: a prospective observational study in Mexico City
    Parra-Ortega, Israel
    Guadalupe Alcara-Ramirez, Diana
    Angelica Ronzon-Ronzon, Alma
    Elias-Garcia, Fermin
    Agustin Mata-Chapol, Jose
    Daniel Cervantes-Cote, Alejandro
    Lopez-Martinez, Briceida
    Angel Villasis-Keever, Miguel
    Nallely Zurita-Cruz, Jessie
    NUTRITION RESEARCH AND PRACTICE, 2021, 15 : S32 - S40
  • [30] Serum 25-hydroxyvitamin D predicts severity in Parkinson's disease patients
    Liu, Ying
    Zhang, Ben-shu
    NEUROLOGICAL SCIENCES, 2014, 35 (01) : 67 - 71